Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.34525 | 70 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.30362 | 69 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.30489 | 69 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.27563 | 69 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.27076 | 69 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.33529 | 70 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.30429 | 69 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.28528 | 69 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.28196 | 69 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.29839 | 69 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.28692 | 69 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.28264 | 69 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.29948 | 69 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.29554 | 69 |